Skip to main content
. 2022 Jun 16;13:927443. doi: 10.3389/fimmu.2022.927443

Figure 7.

Figure 7

IHNV was injected on the 60th day after re-immunization, and the survival rate curve of oral pPG-612-CK6-G/L.casei 393 and the control group was observed within 14 days.